Cannabis and Cannabinoid Research is the premier journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids. The Journal publishes a broad range of human and animal studies including basic and translational research; clinical studies; behavioral, social, and epidemiological issues; and ethical, legal, and regulatory controversies. Cannabis and Cannabinoid Research is the leading source for authoritative cannabis and cannabinoid research, discussion, and debate.
Cannabis and Cannabinoid Research coverage includes:
Cannabis and Cannabinoid Research is under the editorial leadership of Daniele Piomelli, PhD, the Louise Turner Arnold Chair in Neurosciences and Professor of Anatomy and Neurobiology, Pharmacology, and Biological Chemistry at University of California, Irvine. The editorial board is comprised of leading investigators in the field from around the world. View the entire editorial board here.
An annual subscription to Cannabis and Cannabinoid Research is included in membership with the ACS. ACS members receive a 25% discount on submissions to CCR. To see the full list of ACS member benefits, click here.